SGLT2 inhibitors and alteration of substrate metabolism.
Session:
How do SGLT2 inhibitors and incretin-based therapy exert their effects on cardiovascular disease?
Topic:
Diabetes and the Heart
Speaker:
Professor E. Ferrannini (Pisa, IT)
Event:
ESC Congress 2018
Congress Presentation
About the speaker
Professor Ele Ferrannini
CNR – National Research Council, Pisa (Italy)
1
presentation
0
follower
3 more presentations in this session
Epigenetic signatures and cardiovascular risk in diabetes.
Speaker: Professor F. Cosentino (Stockholm, SE)
Access the full session
How do SGLT2 inhibitors and incretin-based therapy exert their effects on cardiovascular disease?
Speakers:
Professor E. Ferrannini, Professor F. Cosentino, Professor L. Ryden, Professor B. Staels
About the event
ESC 365 is supported by
